Skip to content

Drug interactions

Talquetamab + Valproic acid

Severity: Minor

Talquetamab and Valproic acid: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cytokine release syndrome from talquetamab can transiently suppress CYP enzymes, but valproate has limited CYP-dependent clearance, so exposure changes are likely small. Valproate can cause thrombocytopenia and hepatotoxicity, which may complicate management of the cytopenias and liver effects seen with talquetamab.

What this interaction means in plain words

Talquetamab and Valproic acid have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Talquetamab belongs to Oncology; Valproic acid belongs to Central Nervous System.

Evidence level: Low

Why it happens

Cytokine-mediated CYP suppression of minor relevance to valproate.

What to do

Monitor valproate levels, liver tests and blood counts during step-up dosing and any cytokine release syndrome.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Talquetamab and Valproic acid, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Talquetamab with Valproic acid?

MediHelp rates the interaction as minor. Talquetamab and Valproic acid have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Cytokine release syndrome from talquetamab can transiently suppress CYP enzymes, but valproate has limited CYP-dependent clearance, so exposure changes are likely small. Valproate can cause thrombocytopenia and hepatotoxicity, which may complicate management of the cytopenias and liver effects seen with talquetamab.

How serious is the interaction between Talquetamab and Valproic acid?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor valproate levels, liver tests and blood counts during step-up dosing and any cytokine release syndrome.

What other medicines interact with Valproic acid?

MediHelp also lists interactions of Valproic acid with, for example, Ertapenem, Imipenem / cilastatin / relebactam, Imipenem / cilastatin. The full list is on the Valproic acid page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in